The psychedelics boom continues to sweep across the United States, and each week brings a new development for the budding sector. Psychedelic medicine has been showing great promise, so much so that the U.S. FDA and Health Canada have begun to fast-track psychedelic substances such as psilocybin, MDMA and Ketamine for research and development. Suddenly, with the federal government supporting medical research instead of holding it back, the psychedelics industry has truly taken off.

Psilocybin, the active ingredient in Magic Mushrooms, has been stealing the limelight over the past few months thanks to multiple positive legislative developments.

Back in 2019, Denver and Oakland took an important first step to bringing this wonder drug to the masses after they decriminalized psilocybin. Since then, the psilocybin momentum has only continued to accelerate globally. What’s driving the latest shroom boom amid the global pandemic? The same factors that drove the cannabis boom of a few years back: Changing laws, changing science and changing consumer attitudes.

Bearing this in mind, here are some of the best psychedelic/psilocybin stocks to buy for potentially huge gains…CLICK for complete article